Skip to content
Select Your Location
View available investments and insights in your market
Americas
Europe and the Middle East
Asia Pacific

Investing in Volatile Markets

COVID-19 is impacting societies and markets around the world. The below insights from Neuberger Berman thought leaders and senior investment professionals aim to provide guidance and useful knowledge, in real time, to help investors navigate through this uncertain period.
Webinar | Divergence and Bifurcation: Has the Investment Landscape Changed?
Listen to Joe Amato, Erik Knutzen, Brad Tank and Terri Towers, as they looked at the increasing bifurcations within their preferred base case categories along with the development pathway for vaccines in the age of COVID-19 View Replay
Videos: Markets Unscripted
Equity Investing as We Approach a “New Normal”
(3:59) Richard Nackenson, Neuberger Berman Equity Portfolio Manager, discusses how investor psychology has changed over the past month and where he is finding investment opportunities as we approach a “new normal”
PE Investing at Market Inflections
(5:34) Faced with the uncertainties of the COVID-19 crisis and demands for portfolio rebalancing, investors may be tempted to cut their private equity programs or re-think plans to expand them. In this short video interview, John Buser, Executive Vice Chairman—NB Alternatives, looks back to the dotcom era and the Great Financial Crisis to explain why he thinks they should stay the course
Insights
At the Peak of the Curve
After an apparently strong and rapid equity market rally in April, Neuberger Berman’s AAC reconvenes to reassess its views
READ MORE
Digital Drivers of Real Estate Opportunity
Shifts in technology are contributing to a new landscape in the listed real estate universe
READ MORE
Webinars
Divergence and Bifurcation: Has the Investment Landscape Changed?
On May 20th, Joe Amato, Erik Knutzen, Brad Tank and Terri Towers looked at the increasing bifurcations within their preferred base case categories, along with the development pathway for vaccines in the age of
COVID-19
ACCESS REPLAY
Commentaries
Science Can Win on the COVID-19 Vaccine Front
We have discussed the second wave with regard to testing, but now we frame the development pathway for vaccines in the age of COVID-19
Read More
Better Prepared Should There Be a Second Wave
It's safe to say we have flattened the curve, what are the next steps to monitor on the path to returning to "normalcy"?
Read More